Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib can help hair grow back in alopecia patients but hair loss might return if the dose is lowered.

Certain tyrosine kinases may regulate hair growth and could help develop hair loss treatments.

The assay quickly identifies substances that increase or decrease blood vessel growth.

The superficial temporal artery flap is a reliable method for reconstructing complex facial defects with minimal complications.

Telogen Effluvium is a common hair loss condition, particularly in women, with no specific FDA-approved treatment, and recovery can take up to 18 months.

Chemical treatments and UV radiation severely damage the lipid layer on hair.

Rapamycin and anti-EGFR antibody reduce LAM/TSC cell migration and blood vessel growth in the uterus.

Autologous fat transfer improves hair growth in scarring alopecia and allows for denser hair transplants.

Tofacitinib effectively treated severe hair loss in a patient who didn't respond to other treatments.

Hormone therapy for transgender females increases the risk of blood clots and requires careful dosing, monitoring, and lifelong management.

TGF-β inhibitors may help treat liver fibrosis by targeting various pathways.

TrichoTech™ may help hair growth and skin repair by increasing fibroblast growth and activity.

Telogen effluvium is a type of hair loss that happens when stress or illness causes many hairs to enter the resting phase and fall out.

Oral isotretinoin effectively stabilizes frontal fibrosing alopecia.

Light therapy on the brain shows promise for treating brain diseases and improving brain function.

The registry showed that tofacitinib is promising for treating hair loss in children with alopecia areata, but more research is needed.

DTC hair regrowth solutions are improving hair health and confidence with innovative, personalized approaches.

The Cross-section Trichometer is a new tool that can measure hair quantity and detect hair loss and growth.

Tofacitinib, a medication for arthritis, showed potential for treating severe hair loss in a small Brazilian case series, but more research is needed.

Fenoterol treatment causes increased hair growth due to higher metabolism in hair follicles, not hormones.

A girl with a rare genetic disorder had a unique bone condition, highlighting the need for careful diagnosis and suggesting the disorder might be more common than thought.

Traumatic anserine folliculosis is a harmless skin condition in young males that needs correct diagnosis to avoid unnecessary treatments.

Some blood donors on teratogenic drugs may have unsafe drug levels, suggesting a need for better deferral policies.

The paper suggests that telogen effluvium, a type of hair loss, may be a long-lasting condition triggered by stress or illness in people whose hair growth is unusually synchronized.

Tofacitinib helps mice grow more hair by increasing noggin and BMP4 levels, possibly better than minoxidil.

Fractional infrared technology is effective and safe for treating cervical laxity.

TRH stimulates human hair growth and extends the hair growth phase.

Thread-embedding therapy helped hair grow back in mice and might do the same in humans.

Trichostasis spinulosa is common but often underdiagnosed, mainly affecting women's faces.

Telogen effluvium is a common hair loss condition where many hairs enter the resting phase, often not noticeable until significant loss occurs, and treatment focuses on the underlying cause.